Current status of clinical trial registration regarding coronavirus disease 2019

Q4 Biochemistry, Genetics and Molecular Biology 解放军医学杂志 Pub Date : 2020-04-01 DOI:10.11855/J.ISSN.0577-7402.2020.04.04
Feifei Hou, Jun Liu, Zhaoqing Bai, Yan-yan Wu, X. Qi
{"title":"Current status of clinical trial registration regarding coronavirus disease 2019","authors":"Feifei Hou, Jun Liu, Zhaoqing Bai, Yan-yan Wu, X. Qi","doi":"10.11855/J.ISSN.0577-7402.2020.04.04","DOIUrl":null,"url":null,"abstract":"Objective To summarize the main characteristics of clinical studies regarding coronavirus disease 2019 (COVID-19) registered on the Chinese and US NIH Official Clinical Trial Registration Websites. Methods To search all the clinical studies about COVID-19 which were registered on the Chinese and U.S. NIH official clinical trial registration websites until March 9, 2020. The search terms were \"new coronavirus pneumonia (COVID-19), 2019-nCoV, novel coronavirus pneumonia\". Results Overall, 360 studies with a total sample size of 268,773 participants are registered on Chinese clinical trial registration website, and 74 studies with a total sample size of 73,723 participants in the U.S. NIH clinical trial registration website. According to the information provided by the Chinese Clinical Trial Registration Website, there are 237 interventional studies, 108 observational studies, and 15 diagnostic test studies; and the most commonly studied interventions were Traditional Chinese Medicine in 80 studies, antiviral therapy in 58 studies, stem cells in 19 studies, plasma of recovered patients in 13 studies, glucocorticoid in 7 studies, molecular targeted therapy in 4 studies, and vaccine in 2 studies. According to the information provided by the U.S. NIH Clinical Trial Registration Website, there were 54 interventional studies, 17 observational studies, and 3 diagnostic test studies; and the most commonly studied interventions were antiviral therapy in 16 studies, stem cells in 7 studies, Traditional Chinese Medicine in 6 studies, molecular targeted therapy in 3 studies, and vaccine in 3 studies. Conclusions Numerous clinical studies related to COVID-19 have been registered during a very short period. Among them, Traditional Chinese Medicine is the most commonly studied intervention, which suggests the Chinese characteristics in medical care. However, considering such a large sample size needed for these clinical studies, it is very important to ensure the enrollment of participants effectively and orderly in future.\n\nDOI: 10.11855/j.issn.0577-7402.2020.04.04","PeriodicalId":18660,"journal":{"name":"解放军医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"解放军医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.11855/J.ISSN.0577-7402.2020.04.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 1

Abstract

Objective To summarize the main characteristics of clinical studies regarding coronavirus disease 2019 (COVID-19) registered on the Chinese and US NIH Official Clinical Trial Registration Websites. Methods To search all the clinical studies about COVID-19 which were registered on the Chinese and U.S. NIH official clinical trial registration websites until March 9, 2020. The search terms were "new coronavirus pneumonia (COVID-19), 2019-nCoV, novel coronavirus pneumonia". Results Overall, 360 studies with a total sample size of 268,773 participants are registered on Chinese clinical trial registration website, and 74 studies with a total sample size of 73,723 participants in the U.S. NIH clinical trial registration website. According to the information provided by the Chinese Clinical Trial Registration Website, there are 237 interventional studies, 108 observational studies, and 15 diagnostic test studies; and the most commonly studied interventions were Traditional Chinese Medicine in 80 studies, antiviral therapy in 58 studies, stem cells in 19 studies, plasma of recovered patients in 13 studies, glucocorticoid in 7 studies, molecular targeted therapy in 4 studies, and vaccine in 2 studies. According to the information provided by the U.S. NIH Clinical Trial Registration Website, there were 54 interventional studies, 17 observational studies, and 3 diagnostic test studies; and the most commonly studied interventions were antiviral therapy in 16 studies, stem cells in 7 studies, Traditional Chinese Medicine in 6 studies, molecular targeted therapy in 3 studies, and vaccine in 3 studies. Conclusions Numerous clinical studies related to COVID-19 have been registered during a very short period. Among them, Traditional Chinese Medicine is the most commonly studied intervention, which suggests the Chinese characteristics in medical care. However, considering such a large sample size needed for these clinical studies, it is very important to ensure the enrollment of participants effectively and orderly in future. DOI: 10.11855/j.issn.0577-7402.2020.04.04
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019冠状病毒病临床试验注册现状
目的总结中美两国NIH官方临床试验注册网站注册的新型冠状病毒病(COVID-19)临床研究的主要特点。方法检索截至2020年3月9日在中美两国NIH官方临床试验注册网站上注册的所有关于COVID-19的临床研究。检索词为“新型冠状病毒肺炎(COVID-19)、2019-nCoV、新型冠状病毒肺炎”。结果总体而言,在中国临床试验注册网站上注册了360项研究,总样本量为268,773名受试者;在美国NIH临床试验注册网站上注册了74项研究,总样本量为73,723名受试者。根据中国临床试验注册网站提供的信息,介入研究237项,观察研究108项,诊断试验研究15项;最常见的干预措施是80项中药研究、58项抗病毒治疗、19项干细胞研究、13项康复患者血浆治疗、7项糖皮质激素研究、4项分子靶向治疗和2项疫苗研究。根据美国国立卫生研究院临床试验注册网站提供的信息,共有54项介入性研究,17项观察性研究和3项诊断试验研究;最常见的干预措施是抗病毒治疗(16项)、干细胞治疗(7项)、中药治疗(6项)、分子靶向治疗(3项)和疫苗治疗(3项)。在很短的时间内注册了大量与COVID-19相关的临床研究。其中,中医是研究最多的干预手段,在医疗护理中体现出中国特色。然而,考虑到这些临床研究需要如此大的样本量,确保未来有效有序地纳入参与者是非常重要的。DOI: 10.11855 / j.issn.0577-7402.2020.04.04
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
解放军医学杂志
解放军医学杂志 Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
1.00
自引率
0.00%
发文量
14732
期刊介绍:
期刊最新文献
Current status of drug candidates against SARS-CoV-2 Recent advances in vaccine development of severe acute respiratory syndrome coronavirus 2 Analyses of the clinical features of 13 corona virus disease 2019 non-survivors Current status of clinical trial registration regarding coronavirus disease 2019 The interpretation of Consensus on emergency surgery and infection prevention and control for severe trauma patients with 2019 novel corona virus pneumonia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1